Not Signed In - Rockwell Medical Technologies, Inc. Reports Favorable Results For SFP Pre-Clinical Safety Studies
Thu, 25 Jan 2007 08:00 AM EST
... Rockwell Medical Technologies, Inc. (Nasdaq: RMTI), a leading, innovative manufacturer and developer of concentrates and specialty pharmaceuticals focused on the end- stage-renal-disease market (ESRD), reported today that it has received favorable reports from its pre-clinical safety studies for its proprietary iron-delivery product, Soluble Ferric Pyrophosphate (SFP). [click link for full article] ...
Related Topics
- Clinical Trials
- Drug and Medical Device Safety
- Medical Errors
- Pharmacology
- Food Safety
- Drug Safety
- Fire Safety
- Child Safety
- Sports Safety
- Electrical Safety
- Workplace Safety & Health
- Safety (General)
- Traffic Safety
- Understanding Medical Research
- Safety
- Vaccine Safety and Adverse Event Reports
- Medical Care
- Machine Safety
- Medical Education & Training
- Chemical Safety
email this page
print this page
bookmark this page
feedback on this page
